IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $88,125,000 | +133.2% | 1,036,409 | -2.8% | 0.02% | +111.1% |
Q2 2020 | $37,792,000 | +22.5% | 1,066,364 | -53.4% | 0.01% | 0.0% |
Q1 2020 | $30,844,000 | -31.4% | 2,288,143 | +7.6% | 0.01% | -10.0% |
Q4 2019 | $44,993,000 | +55.9% | 2,126,302 | -2.3% | 0.01% | +42.9% |
Q3 2019 | $28,854,000 | +8.3% | 2,176,056 | +13.3% | 0.01% | +16.7% |
Q2 2019 | $26,642,000 | -27.2% | 1,920,907 | +0.9% | 0.01% | -33.3% |
Q1 2019 | $36,582,000 | +35.9% | 1,904,350 | +1.0% | 0.01% | +12.5% |
Q4 2018 | $26,913,000 | -29.5% | 1,886,072 | +2.9% | 0.01% | -11.1% |
Q3 2018 | $38,182,000 | -4.5% | 1,833,049 | +8.5% | 0.01% | -10.0% |
Q2 2018 | $39,992,000 | +117.9% | 1,689,502 | +34.5% | 0.01% | +100.0% |
Q1 2018 | $18,353,000 | -9.1% | 1,256,143 | +0.6% | 0.01% | 0.0% |
Q4 2017 | $20,180,000 | +15.1% | 1,248,747 | -0.4% | 0.01% | 0.0% |
Q3 2017 | $17,531,000 | +55.5% | 1,253,981 | -1.8% | 0.01% | +66.7% |
Q2 2017 | $11,275,000 | +39.9% | 1,276,821 | +2.5% | 0.00% | +50.0% |
Q1 2017 | $8,061,000 | +85.8% | 1,245,895 | +5.4% | 0.00% | +100.0% |
Q4 2016 | $4,338,000 | +27.3% | 1,182,109 | +12.7% | 0.00% | 0.0% |
Q3 2016 | $3,409,000 | +41.5% | 1,048,928 | +1.0% | 0.00% | 0.0% |
Q2 2016 | $2,410,000 | -13.7% | 1,038,770 | -7.0% | 0.00% | 0.0% |
Q1 2016 | $2,793,000 | -15.7% | 1,117,526 | +3.5% | 0.00% | 0.0% |
Q4 2015 | $3,315,000 | +77.8% | 1,080,082 | -0.4% | 0.00% | 0.0% |
Q3 2015 | $1,864,000 | -52.6% | 1,084,020 | +11.9% | 0.00% | 0.0% |
Q2 2015 | $3,932,000 | +6.6% | 968,353 | +0.6% | 0.00% | 0.0% |
Q1 2015 | $3,688,000 | -20.0% | 962,759 | +0.2% | 0.00% | 0.0% |
Q4 2014 | $4,611,000 | +25.6% | 960,579 | -2.7% | 0.00% | 0.0% |
Q3 2014 | $3,671,000 | +1.2% | 986,892 | -0.7% | 0.00% | 0.0% |
Q2 2014 | $3,629,000 | -15.8% | 994,250 | -2.8% | 0.00% | 0.0% |
Q1 2014 | $4,308,000 | -14.4% | 1,023,216 | -6.5% | 0.00% | -50.0% |
Q4 2013 | $5,034,000 | -24.5% | 1,094,320 | +1.8% | 0.00% | 0.0% |
Q3 2013 | $6,664,000 | +15.4% | 1,075,014 | +1.3% | 0.00% | 0.0% |
Q2 2013 | $5,773,000 | – | 1,061,267 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |